US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

1  2  3  4    6    8  9  10  
Covance, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Covance, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
InterMune, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' InterMune, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital ...  |  read more...
USD 350
Verenium Corporation (Formerly Diversa Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Verenium Corporation (Formerly Diversa Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership ...  |  read more...
USD 350
Cytori Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Cytori Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Asuragen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Asuragen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Life Technologies Corporation (formerly Invitrogen Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Life Technologies Corporation (formerly Invitrogen Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ...  |  read more...
USD 350
Sartorius Stedim Biotech S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Sartorius Stedim Biotech S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
ImmunoGen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' ImmunoGen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
AmpliPhi Biosciences Corporation (formerly Targeted Genetics Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' AmpliPhi Biosciences Corporation (formerly Targeted Genetics Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital ...  |  read more...
USD 350
Complete Genomics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Complete Genomics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Global Antisense and RNAi Therapeutics Market 2015-2019
11/12/2014 | published by: TechNavio - Infiniti Research Ltd.
... is a RNA-based gene silencing process in which RNA molecules inhibit gene expression by destructing definite mRNA molecules. Antisense technology involves the synthesis of a strand of nucleic acid that would bind to an mRNA ...  |  read more...
USD 2,500
Global Life Sciences BPO Market 2014-2018
11/12/2014 | published by: TechNavio - Infiniti Research Ltd.
... stringent regulatory environment and the patent expiry of several important drugs are leading to diminishing profit margins to many life science companies. This scenario has forced life science companies to outsource their R&D activities and ...  |  read more...
USD 2,500
Global miRNA Market 2015-2019
11/12/2014 | published by: TechNavio - Infiniti Research Ltd.
... of genes and to control diseases by gene silencing. They interact with mRNA molecules and regulate expression of genes by mRNA cleavage, translational repression, and deadenylation. They are generally 17-27 nucleotides long and regulate post-transcriptional ...  |  read more...
USD 2,500
Advaxis, Inc. (formerly Great Expectations & Associates, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Advaxis, Inc. (formerly Great Expectations & Associates, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture ...  |  read more...
USD 350
Albany Molecular Research, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Albany Molecular Research, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
United Therapeutics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' United Therapeutics Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Five Prime Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Five Prime Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... of the report is to establish the understanding for all the pipeline drugs that fall under Protein Kinase C Beta (PKC-Beta) Inhibitors. This report provides information on the therapeutic development based on the Protein Kinase ...  |  read more...
USD 1,250
Dendritic Cell and CAR-T Therapies Market, 2014-2024
11/20/2014 | published by: Roots Analysis
... / orphan forms. Although oncology continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. The focus of drug developers is gradually moving towards ...  |  read more...
USD 1,899
2014-2018 World Microbiology Market: Latest Instrumentation and Strategic Profiles of Leading Suppliers
11/11/2014 | published by: VPGMarketResearch.com
... and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 86 pages Please note: The delivery time for the electronic version of this report ...  |  read more...
USD 3,500
Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... understanding for all the pipeline drugs that fall under Hematopoietic Stem Cell Transplantation. This report provides information on the therapeutic development based on the Hematopoietic Stem Cell Transplantation dealing with all the pipeline drugs, comparative ...  |  read more...
USD 1,250
World: Case Materials - Market Report. Analysis and Forecast to 2020
11/17/2014 | published by: IndexBox Marketing Ltd.
... domestic production, exports and imports, price dynamics and trends in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of ...  |  read more...
USD 1,900
Biotechnology Product Manufacturing
11/24/2014 | published by: First Research, Inc.
... Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto, as well as CSL (Australia), Merck KGaA (Germany), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). ...  |  read more...
USD 129
Biogen IDEC Inc (BIIB: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Biogen IDEC Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
1  2  3  4    6    8  9  10